Portal de Periódicos da CAPES

Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study

2022; Springer Science+Business Media; Volume: 261; Issue: 2 Linguagem: Inglês

10.1007/s00417-022-05793-5

1435-702X

Tomoko Ueda‐Consolvo, Aya Tanigichi, Ayaka Numata, Toshihiko Oiwake, Tomoko Nakamura, Masaaki Ishida, Shuichiro Yanagisawa, Atsushi Hayashi,

Retinal and Optic Conditions